Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biological variation of tumor markers and its application in the detection of disease progression in patients with non-small cell lung cancer.

Clinical chemistry - 1 Jan 2005

Trapé Jaume, Pérez de Olaguer Joaquim, Buxó Josep, López Laura

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Biomarkers, Tumor
Share to CA-125 Antigen
Share to Carcinoembryonic Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Disease Progression

Share to Keratin-19

Share to Keratins

Source

Identifiers

PMID: 15613716
DOI: 10.1373/clinchem.2004.040659

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Biological variation of tumor markers and its application in the detection of disease progression in patients with non-small cell lung cancer.PMID 15613716Read ↗

Intra‐individual variation of circulating tumour DNA in lung cancer patientsSemantic proximity Read ↗

Beyond histology: translating tumor genotypes into clinically effective targeted therapies.Semantic proximity Read ↗

The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future DirectionsSemantic proximity Read ↗

Genetic Markers in Lung Cancer Diagnosis: A ReviewSemantic proximity Read ↗

Intrapatient variation in PD-L1 expression and tumor mutational burden and implications for outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer.Semantic proximity Read ↗

Mutant-allele dispersion correlates with prognosis risk in patients with advanced non-small cell lung cancer.Semantic proximity Read ↗

Genetic Blueprints in Lung Cancer: Foundations for Targeted TherapiesSemantic proximity Read ↗

Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.